Abstract 3528: The SMARCA2/4 catalytic activity, but not the bromodomain, is a drug target in SWI/SNF mutant cancersBhavatarini Vangamudi, Jannik N. Andersen, Parantu K. Shah et al.|Cancer Research|2015Cited by 0